Caribou Biosciences Stock Cash And Equivalents

CRBU Stock  USD 1.69  0.11  6.11%   
Caribou Biosciences fundamentals help investors to digest information that contributes to Caribou Biosciences' financial success or failures. It also enables traders to predict the movement of Caribou Stock. The fundamental analysis module provides a way to measure Caribou Biosciences' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Caribou Biosciences stock.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Caribou Biosciences Company Cash And Equivalents Analysis

Caribou Biosciences' Cash or Cash Equivalents are the most liquid of all assets found on the company's balance sheet. It is used in calculating many of the firm's liquidity ratios and is a good indicator of the overall financial health of a company. Companies with a lot of cash are usually attractive takeover targets. Cash Equivalents are balance sheet items that are typically reported using currency printed on notes.

Cash

 = 

Bank Deposits

+

Liquidities

More About Cash And Equivalents | All Equity Analysis

Current Caribou Biosciences Cash And Equivalents

    
  339.92 M  
Most of Caribou Biosciences' fundamental indicators, such as Cash And Equivalents, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Caribou Biosciences is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

Caribou Cash And Equivalents Driver Correlations

Understanding the fundamental principles of building solid financial models for Caribou Biosciences is extremely important. It helps to project a fair market value of Caribou Stock properly, considering its historical fundamentals such as Cash And Equivalents. Since Caribou Biosciences' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Caribou Biosciences' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Caribou Biosciences' interrelated accounts and indicators.
1.01.00.86-0.46-0.860.180.530.890.661.00.830.990.990.990.630.990.78-0.490.66-0.49
1.01.00.86-0.48-0.840.20.540.880.641.00.831.00.980.990.650.980.77-0.480.65-0.48
1.01.00.87-0.52-0.810.210.570.840.611.00.820.990.970.990.680.970.76-0.410.61-0.41
0.860.860.87-0.52-0.64-0.090.630.690.670.860.660.840.790.840.670.790.58-0.240.27-0.24
-0.46-0.48-0.52-0.520.0-0.69-0.9-0.10.24-0.48-0.22-0.55-0.32-0.56-0.97-0.320.12-0.170.2-0.17
-0.86-0.84-0.81-0.640.00.1-0.14-0.99-0.84-0.85-0.82-0.81-0.91-0.8-0.21-0.91-0.840.8-0.90.8
0.180.20.21-0.09-0.690.10.56-0.05-0.550.20.130.290.120.30.620.12-0.230.060.030.06
0.530.540.570.63-0.9-0.140.560.190.010.540.490.590.410.60.960.41-0.040.12-0.140.12
0.890.880.840.69-0.1-0.99-0.050.190.80.880.780.860.920.850.290.920.81-0.810.87-0.81
0.660.640.610.670.24-0.84-0.550.010.80.640.720.570.710.55-0.010.710.79-0.560.62-0.56
1.01.01.00.86-0.48-0.850.20.540.880.640.831.00.980.990.650.980.77-0.480.65-0.48
0.830.830.820.66-0.22-0.820.130.490.780.720.830.80.870.790.440.870.72-0.450.66-0.45
0.991.00.990.84-0.55-0.810.290.590.860.571.00.80.961.00.70.960.71-0.470.63-0.47
0.990.980.970.79-0.32-0.910.120.410.920.710.980.870.960.960.511.00.86-0.540.76-0.54
0.990.990.990.84-0.56-0.80.30.60.850.550.990.791.00.960.710.960.7-0.470.62-0.47
0.630.650.680.67-0.97-0.210.620.960.29-0.010.650.440.70.510.710.510.060.04-0.040.04
0.990.980.970.79-0.32-0.910.120.410.920.710.980.870.961.00.960.510.86-0.540.76-0.54
0.780.770.760.580.12-0.84-0.23-0.040.810.790.770.720.710.860.70.060.86-0.440.79-0.44
-0.49-0.48-0.41-0.24-0.170.80.060.12-0.81-0.56-0.48-0.45-0.47-0.54-0.470.04-0.54-0.44-0.831.0
0.660.650.610.270.2-0.90.03-0.140.870.620.650.660.630.760.62-0.040.760.79-0.83-0.83
-0.49-0.48-0.41-0.24-0.170.80.060.12-0.81-0.56-0.48-0.45-0.47-0.54-0.470.04-0.54-0.441.0-0.83
Click cells to compare fundamentals
Cash equivalents represent current assets that are easily convertible to cash such as short term bonds, savings account, money market funds, or certificate of deposits (CDs). One of the important consideration companies make when classifying assets as cash equivalent is that investments they report on their balance sheets under current assets should have almost no risk of change in value over the next few months (usually three months).
Competition

Caribou Cash And Cash Equivalents Changes

Cash And Cash Equivalents Changes

(155.68 Million)

At this time, Caribou Biosciences' Cash And Cash Equivalents Changes is comparatively stable compared to the past year.
In accordance with the recently published financial statements, Caribou Biosciences has 339.92 M in Cash And Equivalents. This is 58.59% lower than that of the Biotechnology sector and 23.98% lower than that of the Health Care industry. The cash and equivalents for all United States stocks is 87.42% higher than that of the company.

Caribou Cash And Equivalents Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Caribou Biosciences' direct or indirect competition against its Cash And Equivalents to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Caribou Biosciences could also be used in its relative valuation, which is a method of valuing Caribou Biosciences by comparing valuation metrics of similar companies.
Caribou Biosciences is currently under evaluation in cash and equivalents category among its peers.

Caribou Fundamentals

About Caribou Biosciences Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Caribou Biosciences's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Caribou Biosciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Caribou Biosciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Caribou Stock Analysis

When running Caribou Biosciences' price analysis, check to measure Caribou Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Caribou Biosciences is operating at the current time. Most of Caribou Biosciences' value examination focuses on studying past and present price action to predict the probability of Caribou Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Caribou Biosciences' price. Additionally, you may evaluate how the addition of Caribou Biosciences to your portfolios can decrease your overall portfolio volatility.